Natus Medical, Inc. (BABY) Tops Q4 EPS by 5c; Keeps Flat Revs Outlook for FY14
Tweet Send to a Friend
Natus Medical, Inc. (NASDAQ: BABY) reported Q4 EPS of $0.37, $0.05 better than the analyst estimate of $0.32. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
